Journals / Journal of Istanbul University Faculty of Dentistry / 2017 / Cilt: 51 - Sayı: 3

Cerrahi Destekli Hızlı Üst Çene Genişletmesi Sırasında Damar İçi Traneksamik Asit Kullanımı Kan Kaybını Azaltır mı?

DOES INTRAVENOUS TRANEXAMIC ACID REDUCE BLOOD LOSS DURING SURGICALLY ASSISTED RAPID PALATAL EXPANSION?

Pages
32–37
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Purpose: The purpose of this study was to evaluate the efficacy of tranexamic acid (TXA) in reducing blood loss during surgically assisted rapid palatal expansion (SARPE) procedure.Subjects and Methods: A total of 34 patients (12 male, 22 female) who had been treated surgically under general anesthesia with SARPE including pterygoid disjunction for transverse maxillary deficiency (TMD) were included in this study.
📊
Key Findings & Data:The study group (n=17) received intravenous (IV) TXA 10 mg/kg as a preoperative bolus; the control group (n=17) received normal saline solution.
💡
Conclusion & Impact:Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Purpose: The purpose of this study was to evaluate the efficacy of tranexamic acid (TXA) in reducing blood loss during surgically assisted rapid palatal expansion (SARPE) procedure.Subjects and Methods: A total of 34 patients (12 male, 22 female) who had been treated surgically under general anesthesia with SARPE including pterygoid disjunction for transverse maxillary deficiency (TMD) were included in this study. The study group (n=17) received intravenous (IV) TXA 10 mg/kg as a preoperative bolus; the control group (n=17) received normal saline solution. Preoperative and postoperative haemoglobin and haematocrit values, intraoperative blood loss, and any blood product transfusion were recorded. Results: Blood loss during SARPE was statistically significantly less in the study group than the control group (p=0.0001).Conclusion: Preoperative IV administration of TXA can effectively control blood loss during when SARPE with pterygoid disjunction is performed

Özet

Amaç: Bu çalışmada damar içi traneksamik asit (TXA) kullanımının cerrahi destekli hızlı üst çene genişletmesi sırasında (SARPE) sırasında meydana gelen kan kaybı üzerine etkisinin değerlendirilmesi amaçlanmıştır.Hastalar ve Yöntem: Bu çalışmaya üst çenede transvers yetersizliği (ÜTY) bulunan ve genel anestezi altında pterigoid ayırma yapılarak SARPE ile tedavi edilen toplamda 34 hasta (12 erkek, 22 kadın) dahil edilmiştir. Çalışma grubuna (n=17) damar içi 10 mg/kg TXA girişim öncesinde; kontrol grubuna ise (n=17) yine damar içine serum fizyolojik verilmiştir. Girişim öncesinde ve sonrasında hemoglobin ve hematokrit değerleri, girişim sırasındaki kan kaybı ve kan ürünleri transfüzyonu kaydedilmiştir.Bulgular: SARPE girişimi sırasında çalışma grubunda ölçülen kan kaybı değerlerinin kontrol grubuna göre daha düşük olduğu ve bu farkın istatistiksel olarak çok ileri düzeyde anlamlı olduğu belirlenmiştir (p=0.0001).Sonuç: Girişim öncesinde damar içi yolla TXA uygulaması ile pterigoid ayırma yapılan SARPE işlemi sırasında meydana gelen kan kaybı etkili bir şekilde kontrol altına alınabilir

🔖

Cite This Article

CANSIZ, E., ÇEBİ, Z., AKBAŞ, E., İŞLER, S. C., ÇAKARER, S. (2022). Cerrahi Destekli Hızlı Üst Çene Genişletmesi Sırasında Damar İçi Traneksamik Asit Kullanımı Kan Kaybını Azaltır mı?. Journal of Istanbul University Faculty of Dentistry, Cilt: 51 - Sayı: 3, 32–37. https://ajindex.com/articles/563766

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Handelman CS. Nonsurgical rapid maxillary alveolar expansion in adults: A clinical evaluation. Angle Orthod 1997;67(4):291-305; discussion 306-298
  2. Verlinden CR, Gooris PG, Becking AG. Complications in transpalatal distraction osteogenesis: A retrospective clinical study. J Oral Maxillofac Surg 2011;69(3):899-905
  3. Babacan H, Sokucu O, Doruk C, Ay S. Rapid maxillary expansion and surgically assisted rapid maxillary expansion effects on nasal volume. Angle Orthod 2006;76(1):66-71
  4. Greenbaum KR, Zachrisson BU. The effect of palatal expansion therapy on the periodontal supporting tissues. Am J Orthod 1982;81(1):12- 21
  5. Haas AJ. Long-term posttreatment evaluation of rapid palatal expansion. Angle Orthod 1980;50(3):189-217
  6. Langford SR, Sims MR. Root surface resorption, repair, and periodontal attachment following rapid maxillary expansion in man. Am J Orthod 1982;81(2):108-115. 7
  7. Lanigan DT, Mintz SM. Complications of surgically assisted rapid palatal expansion: Review of the literature and report of a case. J Oral Maxillofac Surg 2002;60(1):104-110
  8. Mommaerts MY. Transpalatal distraction as a method of maxillary expansion. Br J Oral Maxillofac Surg 1999;37(4):268-272
  9. Song G, Yang P, Hu J, Zhu S, Li Y, Wang Q. The effect of tranexamic acid on blood loss in orthognathic surgery: A meta-analysis of randomized controlled trials. Oral Surg Oral Med Oral Pathol Oral Radiol 2013;115(5):595-600
  10. Timms DJ. A study of basal movement with rapid maxillary expansion. Am J Orthod 1980;77(5):500-507
  11. Hynes M, Calder P, Scott G. The use of tranexamic acid to reduce blood loss during total knee arthroplasty. Knee 2003;10(4):375-377
  12. Ho KM, Ismail H. Use of intravenous tranexamic acid to reduce allogeneic blood transfusion in total hip and knee arthroplasty: A meta-analysis. Anaesth Intensive Care 2003;31(5):529-537
  13. Neilipovitz DT. Tranexamic acid for major spinal surgery. Eur Spine J 2004;13 Suppl 1:S62-65
  14. Laupacis A, Fergusson D. Drugs to minimize perioperative blood loss in cardiac surgery: Metaanalyses using perioperative blood transfusion as the outcome. The international study of perioperative transfusion (ISPOT) investigators. Anesth Analg 1997;85(6):1258-1267
  15. Dunn CJ, Goa KL. Tranexamic acid: A review of its use in surgery and other indications. Drugs 1999;57(6):1005-1032
  16. Patatanian E, Fugate SE. Hemostatic mouthwashes in anticoagulated patients undergoing dental extraction. Ann Pharmacother 2006;40(12):2205-